You are here: Industry Insights > API

News List

With First Chinese Small-molecule Oral Drug for COVID-19 Coming, What New Opportunities are Ushered in by the Relevant Industry Chain？ PharmaSources.com/Yefenghong
May 23, 2022
News about the progress of Chinese small-molecule oral? antiviral drug for COVID-19 has been disclosed in recent days and the related R&D ushers in a critical point.
Spinosad Powder Manufacturers in China PharmaSources
August 16, 2021
Spinosad is a naturally occurring substance. It is produced by a soil bacterium. Spinosad is toxic to insects and is a mixture of two compounds; spinosyn A and spinosyn D.
Inositol API Market Size & Trends and Manufacturers in China PharmaSources.com
July 28, 2021
This chemical is carbocyclic sugar. It is found in abundant quantities in the mammalian brain and other tissues.
Cefdinir API Market Size & Trends PharmaSources
July 13, 2021
Cefdinir is a 3rd generation cephalosporin (antibiotic). It is used to treat gram-negative and gram-positive infections of the sinus, throat, lungs, skin, and ear.
Formulation development of New chemical Entities (NCE’s) to commercialization Deepak Hegde
June 16, 2021
The process of taking a new drug from concept to clinic and eventually to commercialization involves several steps which traditionally occur in series.
Continuous Manufacturing Part 2: Industrial Adoption of Continuous Pharmaceutical Manufacturing Deepak Hegde
May 10, 2021
This article, which is Part 2 of the series on continuous manufacturing focuses on the uptake of continuous manufacturing by the pharmaceutical industry for both API and drug products, scaleup to pilot scale and successes in commercialization.
Sevoflurane Introduction, Uses, and Top Sevoflurane API Manufacturers in China PharmaSources.com
May 08, 2021
Side Effects，Manufacturing Process，Sevoflurane Forms and Specifications，ect., of Sevoflurane
Continuous Manufacturing Part 1: Advantages to Drug Companies to Approach Continuous Manufacturing Deepak Hegde
March 11, 2021
Learning what are the features attracting big pharma and generic companies to approach Continuous Manufacturing process from Batch Manufacturing process by reading Dr. Deepak Hegde's Continuous Manufacturing series articles.
Opportunities for China–UK trade in a post-Brexit world Sarah Harding
February 25, 2021
On the final day of 2020, at 11 pm (GMT), the UK finally completed its separation from the European Union (EU).
2020 Zhejiang Export Commodity Online Fair “Russia – API session” is now launched! PharmaSources.com
October 27, 2020
The portals for the “Russia - API session” is now launched to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as Russian buyers online.